topic

A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer
Giulia Marelli, Louisa S Chard Dunmall, Ming Yuan, Carmela Di Gioia, Jinxin Miao, Zhenguo Cheng, Zhongxian Zhang, Peng Liu, Jahangir Ahmed, Rathi Gangeswaran, Nicholas Lemoine, Yaohe Wang

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001624; DOI: 10.1136/jitc-2020-001624
Rethinking immune checkpoint blockade: ‘Beyond the T cell’
Xiuting Liu, Graham D Hogg, David G DeNardo

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001460; DOI: 10.1136/jitc-2020-001460
IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
Tianyue Chen, Xiangqing Ding, Qibin Liao, Nan Gao, Ye Chen, Chen Zhao, Xiaoyan Zhang, Jianqing Xu

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001647; DOI: 10.1136/jitc-2020-001647
Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity
Xiaofei Yu, Wenjie Liu, Shixian Chen, Xueqian Cheng, Patrick A Paez, Tuanwei Sun, Fang Yuan, Chunyan Wei, Joseph W Landry, Andrew S Poklepovic, Harry D Bear, John R Subjeck, Elizabeth Repasky, Chunqing Guo, Xiang-Yang Wang

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001595; DOI: 10.1136/jitc-2020-001595
Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
Chunxiao Li, Xiaofei Xu, Shuhua Wei, Ping Jiang, Lixiang Xue, Junjie Wang

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001341; DOI: 10.1136/jitc-2020-001341
Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e001931corr1; DOI: 10.1136/jitc-2020-001931corr1
Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection
Erin M Hall, Dwight E Yin, Rakesh K Goyal, Atif A Ahmed, Grace S Mitchell, Shawn D St. Peter, Terrie G Flatt, Ibrahim A Ahmed, Weijie Li, Richard J Hendrickson, Keith J August, G Doug Myers

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001225; DOI: 10.1136/jitc-2020-001225
Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
Zi Yin, Min Yu, Tingting Ma, Chuanzhao Zhang, Shanzhou Huang, Mohammad Reza Karimzadeh, Amir Abaas Momtazi-Borojeni, Sheng Chen

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001698; DOI: 10.1136/jitc-2020-001698
Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β
Demi Brownlie, Dahlia Doughty-Shenton, Daniel YH Soong, Colin Nixon, Neil O Carragher, Leo M Carlin, Takanori Kitamura

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001740; DOI: 10.1136/jitc-2020-001740
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
Margaret Gatti-Mays, James L Gulley

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e002252; DOI: 10.1136/jitc-2020-002252

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages